Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2009, Article ID 674801, 7 pages
http://dx.doi.org/10.1155/2009/674801
Clinical Study

Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan Children

1Laboratoire de cytométrie en flux, Institut National d'Hygiène, 10 000 Rabat, Morocco
2Service d'hématologie et oncologie pédiatrique, Hôpital 20 Août, 20 000 Casablanca, Morocco
3Unité d'hémato-oncologie pédiatrique (UHOP), Hôpital d'enfants, 10 000 Rabat, Morocco

Received 9 January 2009; Accepted 27 May 2009

Academic Editor: Eva C. Guinan

Copyright © 2009 Fatima Bachir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Jaffe, N. L. Haris, H. Stein, and J. W. Vardiman, Eds., Pathology and Genetics of Tumours of Heamtopoietic and Lymphoid Tissues, WHO Classification of tumours of Haematopoitic and Lymphoid Tissues, 2001.
  2. P. Kebriaei, J. Anastasi, and R. A. Larson, “Acute lymphoblastic leukemia: diagnosis and classification,” Best Practice and Research: Clinical Haematology, vol. 15, no. 4, pp. 597–521, 2003. View at Google Scholar
  3. N. Dakka, H. Bellaoui, M. Khattab et al., “Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco,” Journal of Pediatric Hematology/Oncology, vol. 29, no. 8, pp. 574–580, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. S. C. Howard, M. Pedrosa, M. Lins et al., “Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area,” Journal of the American Medical Association, vol. 291, no. 20, pp. 2471–2475, 2004. View at Publisher · View at Google Scholar · View at PubMed
  5. P. L. Greenberg, V. Gordeuk, S. Issaragrisil et al., “Major hematologic diseases in the developing world—new aspects of diagnosis and management of thalassemia, malarial anemi, and acute leukemia,” Hematology, pp. 479–498, 2001. View at Google Scholar
  6. F. Msefer Alaoui, “Les cancers de l'enfant: epidemiologie et carcinogenese,” Revue Marocaine des Maladies de l'Enfant, vol. 4, pp. 6–9, 2004. View at Google Scholar
  7. F. Msefer Alaoui, “Les cancers de l'enfant au Maroc: etat desw lieux,” Esperance Medicale, vol. 9, no. 80, pp. 64–65, 2002. View at Google Scholar
  8. M. C. Bene, G. Castoldi, W. Knapp et al., “Proposals for the immunological classification of acute leukemias,” Leukemia, vol. 9, no. 10, pp. 1783–1786, 1995. View at Google Scholar
  9. D. Campana and F. G. Behm, “Immunophenotyping of leukemia,” Journal of Immunological Methods, vol. 243, no. 1-2, pp. 59–75, 2000. View at Publisher · View at Google Scholar
  10. D. Campana and E. Coustan-Smith, “Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia,” Best Practice and Research: Clinical Haematology, vol. 15, no. 1, pp. 1–19, 2002. View at Publisher · View at Google Scholar · View at PubMed
  11. E. Coustan-Smith, J. Sancho, M. L. Hancock et al., “Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia,” Blood, vol. 96, no. 8, pp. 2691–2696, 2000. View at Google Scholar
  12. M. J. Borowitz, K. L. Guenther, K. E. Shults, and G. T. Stelzer, “Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis,” American Journal of Clinical Pathology, vol. 100, no. 5, pp. 534–540, 1993. View at Google Scholar
  13. C.-H. Pui and W. E. Evans, “Acute lymphoblastic leukemia,” The New England Journal of Medicine, vol. 339, no. 9, pp. 605–615, 1998. View at Publisher · View at Google Scholar
  14. C.-H. Pui, F. G. Behm, and W. M. Crist, “Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia,” Blood, vol. 82, no. 2, pp. 343–362, 1993. View at Google Scholar
  15. M. C. Putti, R. Rondelli, M. G. Cocito et al., “Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88- 91 studies,” Blood, vol. 92, no. 3, pp. 795–801, 1998. View at Google Scholar
  16. R. Garand and M. C. Bene, “A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984–1994 the GEIL experience,” Leukemia & Lymphoma, vol. 13, supplement 1, pp. 1–5, 1994. View at Google Scholar
  17. C.-H. Pui, J. M. Boyett, G. K. Rivera et al., “Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital,” Leukemia, vol. 14, no. 12, pp. 2286–2294, 2000. View at Publisher · View at Google Scholar
  18. M. Schrappe, A. Reiter, M. Zimmermann et al., “Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995,” Leukemia, vol. 14, no. 12, pp. 2205–2222, 2000. View at Publisher · View at Google Scholar
  19. P. S. Gaynon, M. E. Trigg, N. A. Heerema et al., “Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995,” Leukemia, vol. 14, no. 12, pp. 2223–2233, 2000. View at Publisher · View at Google Scholar
  20. H. Bellaoui, M. Khattab et al., “Etude du profil Immunologique des leucémies aigues lymphoblastiques de l'enfant au Maroc. Intérêt de l'étude de la coexpression CD34 et CD10,” Biologie & Santé, vol. 3, no. 1, 2003. View at Google Scholar
  21. H. S. Khalidi, K. L. Chang, L. J. Medeiros et al., “Acute lymphoblastic leukemia: survey of immunophenotype, French- American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases,” American Journal of Clinical Pathology, vol. 111, no. 4, pp. 467–476, 1999. View at Google Scholar
  22. M. F. Greaves, S. M. Colman, M. E. J. Beard et al., “Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the collaborative group study,” Leukemia, vol. 7, no. 1, pp. 27–34, 1993. View at Google Scholar
  23. C.-H. Pui, F. G. Behm, B. Singh et al., “Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia,” Blood, vol. 75, no. 1, pp. 174–179, 1990. View at Google Scholar
  24. Z. Kaleem, E. Crawford, M. H. Pathan et al., “Flow cytometric analysis of acute leukemias: diagnostic utility and critical analysis of data,” Archives of Pathology and Laboratory Medicine, vol. 127, no. 1, pp. 42–48, 2003. View at Google Scholar
  25. L. C. Brown and H. H. M. Knox-Macaulay, “Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman,” Leukemia Research, vol. 27, no. 7, pp. 649–654, 2003. View at Publisher · View at Google Scholar
  26. R. Paredes-Aguilera, L. Romero-Guzman, N. Lopez-Santiago, L. Burbano-Ceron, O. Camacho-Del Monte, and S. Nieto-Martinez, “Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia,” American Journal of Hematology, vol. 68, no. 2, pp. 69–74, 2001. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Orfao, F. Ortuño, M. de Santiago, A. Lopez, and J. San Miguel, “Immunophenotyping of acute leukemias and myelodysplastic syndromes,” Cytometry A, vol. 58, no. 1, pp. 62–71, 2004. View at Google Scholar
  28. I. M. Hann, S. M. Richards, O. B. Eden, and F. G. H. Hill, “Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia trial XI (MRC UKALLXI),” Leukemia, vol. 12, no. 8, pp. 1249–1255, 1998. View at Google Scholar
  29. M. J. Borowitz, J. Shuster, A. J. Carroll et al., “Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group study,” Blood, vol. 89, no. 11, pp. 3960–3966, 1997. View at Google Scholar
  30. R. Consolini, A. Legitimo, R. Rondelli et al., “Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP),” Haematologica, vol. 83, no. 11, pp. 967–973, 1998. View at Google Scholar
  31. F. M. Uckun, M. G. Sensel, L. Sun et al., “Biology and treatment of childhood T-lineage acute lymphoblastic leukemia,” Blood, vol. 91, no. 3, pp. 735–746, 1998. View at Google Scholar
  32. D. Campana and C.-H. Pui, “Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance,” Blood, vol. 85, no. 6, pp. 1416–1434, 1995. View at Google Scholar
  33. C.-H. Pui, S. C. Raimondi, D. R. Head et al., “Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse,” Blood, vol. 78, no. 5, pp. 1327–1337, 1991. View at Google Scholar